Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 359 | 544 | 1,010 | 827 | 749 |
| Receivables | 88 | 787 | 438 | 113 | 103 |
| Inventories | 376 | 688 | 728 | 243 | 250 |
| Other current assets | 206 | 193 | 167 | 2,702 | 2,620 |
| TOTAL | $1,029 | $2,212 | $2,343 | $3,885 | $3,723 |
| Non-Current Assets | |||||
| PPE Net | 929 | 966 | 1,001 | 1,031 | 1,066 |
| Intangibles | 536 | 727 | 730 | 721 | 733 |
| Other Non-Current Assets | 0 | 0 | 0 | 162 | 159 |
| TOTAL | $1,465 | $1,693 | $1,731 | $1,914 | $1,958 |
| Total Assets | $2,494 | $3,905 | $4,074 | $5,799 | $5,681 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 344 | 333 | 321 | 7,020 | 6,965 |
| Accounts payable and accrued liabilities | 1,186 | 700 | 511 | 514 | 437 |
| Accrued Expenses | 642 | 1,604 | 1,295 | 1,348 | 1,174 |
| Other current liabilities | 120 | N/A | N/A | 2,589 | 1,448 |
| TOTAL | $2,410 | $2,760 | $2,844 | $12,315 | $10,894 |
| Non-Current Liabilities | |||||
| Long Term Debt | 958 | 1,049 | 1,136 | 1,221 | 1,302 |
| Deferred Revenues | 0 | 0 | 595 | 724 | 751 |
| Other Non-Current Liabilities | 0 | 0 | 0 | -1,415 | -1,320 |
| TOTAL | $1,713 | $1,834 | $1,951 | $3,017 | $3,196 |
| Total Liabilities | $4,123 | $4,594 | $4,796 | $15,333 | $14,090 |
| Shareholders' Equity | |||||
| Common Shares | 24,402 | 24,380 | 23,806 | 23,686 | 23,686 |
| Retained earnings | -34,415 | -33,332 | -32,726 | -43,530 | -42,134 |
| Other shareholders' equity | 66 | 66 | 141 | 141 | 141 |
| TOTAL | $-1,629 | $-689 | $-722 | $-11,732 | $-10,558 |
| Total Liabilities And Equity | $2,494 | $3,905 | $4,074 | $3,601 | $3,532 |